Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial

BACKGROUND: Palliative systemic treatment in elderly gynaecological cancer patients remains a major challenge. In recurrent ovarian cancer (ROC), treosulfan an active alkylating drug showed similar cytotoxicity whether as oral (p.o.) or intravenous (i.v.) application. The aim of this innovative tria...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Gynecol Oncol Res Pract
Auteurs principaux: Chekerov, Radoslav, Harter, Philipp, Fuxius, Stefan, Hanker, Lars Christian, Woelber, Linn, Müller, Lothar, Klare, Peter, Abenhardt, Wolfgang, Nedkova, Yoana, Yalcinkaya, Isil, Heinrich, Georg, Sommer, Harald, Mahner, Sven, Wimberger, Pauline, Koensgen-Mustea, Dominique, Richter, Rolf, Oskay-Oezcelik, Gülten, Sehouli, Jalid
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341434/
https://ncbi.nlm.nih.gov/pubmed/28286660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40661-017-0040-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires